Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents: assessment of harmful effects in non-randomised studies

Ole Jakob Storebø*, Nadia Pedersen, Erica Ramstad, Helle B. Krogh, Carlos R. Moreira-Maia, Frederik L. Magnusson, Mathilde Holmskov, Trine Danvad Nilausen, Maria Skoog, Susanne Rosendal, Camilla Groth, Donna Gillies, Kirsten Buch Rasmussen, Dorothy Gauci, Morris Zwi, Richard Kirubakaran, Bente Forsbøl, Sasja Jul Håkonsen, Lise Aagaard, Erik SimonsenChristian Gluud

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

180 Citations (Scopus)

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the harmful effects of methylphenidate treatment for children and adolescents with attention deficit hyperactivity disorder (ADHD) in non-randomised studies.

Original languageEnglish
Article numberCD012069
JournalCochrane Database of Systematic Reviews
Volume2016
Issue number2
Number of pages20
ISSN1361-6137
DOIs
Publication statusPublished - 2016

Fingerprint

Dive into the research topics of 'Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents: assessment of harmful effects in non-randomised studies'. Together they form a unique fingerprint.

Cite this